Synopsis: Medplus Health Services Limited reported weak Q1 FY27 results as net profit fell 48.44% QoQ to ₹33 crore despite 21.84% revenue growth, indicating margin pressure.
This Small-Cap Pharma Stock, engaged in operating pharmacy stores, diagnostic centres, and e-pharmacy services while supplying medicines, healthcare products, wellness items, and medical essentials across India, crashed 17.80 percent after the company reported June quarterly results with a 48.44 percent QoQ decrease in net profit.
With a market capitalization of Rs. 7,956.08 crores, the share of Medplus Health Services Limited has reached an intraday low of Rs. 653.80 per equity share, crashing nearly 17.80 percent from its previous day’s close price of Rs. 795.40. Since then, the stock has recovered and is currently trading at Rs. 663 per equity share.
Q1 FY27 Result Walkthrough
Coming into the quarterly results of Medplus Health Services Limited, the company’s consolidated revenue from operations increased by 21.84 percent YOY, from Rs. 1,543 crore in Q1 FY26 to Rs. 1,880 crore in Q1 FY27, and grew by 0.85 percent QoQ from Rs. 1,864 crore in Q4 FY26.
In Q1 FY27, Medplus Health Services Limited’s consolidated net profit decreased by 21.43 percent YOY, reaching Rs. 33 crore compared to Rs. 42 crore during the same period last year. As compared to Q4 FY26, the net profit has decreased by 48.44 percent, from Rs. 64 crore. The basic earnings per share decreased by 22.03 percent and stood at Rs. 2.76 as against Rs. 3.54 recorded in the same quarter in the previous year, FY2026.
Business Highlights
MedPlus Health Services Limited is one of India’s leading pharmacy retail chains and has built a strong presence over the last 20 years. The company operates around 5,476 stores across 13 states and 1 union territory, serving customers in nearly 850 cities.
The company follows a cluster-based expansion strategy to strengthen its market presence and employs more than 30,000 people. MedPlus also has a well-managed product portfolio with around 51,000 SKUs across its warehouses and stores.
The company has approximately 1,470 stores that are expected to become profitable as they mature, supporting future growth. It also maintains strong store-level profitability with a Return on Capital Employed (ROCE) of over 60 percent. With its wide store network, omnichannel presence, and focus on operational efficiency, MedPlus continues to strengthen its position in India’s pharmacy retail market.
Store Network
MedPlus Health Services Limited continued to expand its store network during the last year. The company added 663 stores over the past 12 months, increasing its total store count from 4,813 in June 2025 to 5,476 in June 2026. It has a presence in 13 states, 1 union territory, and over 850 cities, with a strong focus on major urban markets across India.
During Q1 FY27, MedPlus opened 222 new stores and closed 52 stores, resulting in a net addition of 170 stores. Most store closures were due to franchise withdrawals, relocations, and other operational reasons. The company continues to expand its retail network while improving the quality and efficiency of its store operations.
Company Overview
MedPlus Health Services Limited is an Indian pharmacy and healthcare retail company headquartered in Hyderabad, Telangana. It operates one of the country’s largest organized pharmacy chains through a combination of physical stores and digital healthcare services, with a presence spanning hundreds of cities across India.
Annual Performance of FY26
Medplus Health Services Limited’s revenue has increased from Rs. 6,136 crore in FY25 to Rs. 6,892 crore in FY26, which has grown by 12.32 percent. The net profit has also grown by 46.67 percent from Rs. 150 crore in FY25 to Rs. 220 crore in FY26.
Medplus Health Services Limited’s revenue and net profit have grown at a CAGR of 18 percent and 29 percent, respectively, over the last five years. In terms of return ratios, the company’s ROCE and ROE stand at 12.6 percent and 11.8 percent, respectively. Medplus Health Services Limited’s debt-to-equity ratio is 0.72x.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
